NCT00017433 2020-10-06Arsenic Trioxide in Treating Patients With Multiple MyelomaCTI BioPharmaPhase 2 Terminated
NCT00017069 2020-10-05Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple MyelomaCTI BioPharmaPhase 2 Terminated
NCT00006220 2013-02-06Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous TherapyWashington University School of MedicinePhase 1/2 Terminated5 enrolled
NCT00227682 2012-05-28Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple MyelomaOHSU Knight Cancer InstitutePhase 2 Terminated2 enrolled